Cargando…
Evaluating the In Vitro Activity and Safety of Modified LfcinB Peptides as Potential Colon Anticancer Agents: Cell Line Studies and Insect-Based Toxicity Assessments
[Image: see text] Anticancer peptides are increasingly being considered as alternative treatments for cancer due to their potency, selectivity, and low toxicity. Previously, the peptide LfcinB (21–25)(Pal) showed in vitro anticancer effects against the Caco-2 colon cancer cell line (half-maximal inh...
Autores principales: | Cárdenas-Martínez, Karen J., Barragán-Cárdenas, Andrea C., de la Rosa-Arbeláez, Manuela, Parra-Giraldo, Claudia M., Ochoa-Zarzosa, Alejandra, Lopez-Meza, Joel E., Rivera-Monroy, Zuly J., Fierro-Medina, Ricardo, García-Castañeda, Javier E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586019/ https://www.ncbi.nlm.nih.gov/pubmed/37867694 http://dx.doi.org/10.1021/acsomega.3c03455 |
Ejemplares similares
-
The tetrameric peptide LfcinB (20–25)(4) derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell line
por: Guerra, Jorge Rodríguez, et al.
Publicado: (2019) -
Non-natural amino acids into LfcinB-derived peptides: effect in their (i) proteolytic degradation and (ii) cytotoxic activity against cancer cells
por: Insuasty-Cepeda, Diego Sebastián, et al.
Publicado: (2023) -
Pullulan nanofibers containing the antimicrobial palindromic peptide LfcinB (21–25)(Pal) obtained via electrospinning
por: Román, Julieth Tatiana, et al.
Publicado: (2019) -
Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans
por: Chang, Che-Kang, et al.
Publicado: (2021) -
Improved diabetic wound healing by LFcinB is associated with relevant changes in the skin immune response and microbiota
por: Mouritzen, Michelle V., et al.
Publicado: (2021)